Literature DB >> 17194738

Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.

E Dermitzaki1, C Tsatsanis, V Minas, E Chatzaki, I Charalampopoulos, M Venihaki, A Androulidaki, M Lambropoulou, J Spiess, E Michalodimitrakis, A Gravanis, A N Margioris.   

Abstract

Corticotropin-releasing factor (CRF) affects catecholamine production both centrally and peripherally. The aim of the present work was to examine the presence of CRF, its related peptides, and their receptors in the medulla of human and rat adrenals and their direct effect on catecholamine synthesis and secretion. CRF, urocortin I (UCN1), urocortin II (UCN2), and CRF receptor type 1 (CRF1) and 2 (CRF2) were present in human and rat adrenal medulla as well as the PC12 pheochromocytoma cells by immunocytochemistry, immunofluorescence, and RT-PCR. Exposure of dispersed human and rat adrenal chromaffin cells to CRF1 receptor agonists induced catecholamine secretion in a dose-dependent manner, an effect peaking at 30 min, whereas CRF2 receptor agonists suppressed catecholamine secretion. The respective effects were blocked by CRF1 and CRF2 antagonists. CRF peptides affected catecholamine secretion via changes of subplasmaliminal actin filament polymerization. CRF peptides also affected catecholamine synthesis. In rat chromaffin and PC12 cells, CRF1 and CRF2 agonists induced catecholamine synthesis via tyrosine hydroxylase. However, in human chromaffin cells, activation of CRF1 receptors induced tyrosine hydroxylase, whereas activation of CRF2 suppressed it. In conclusion, it appears that a complex intraadrenal CRF-UCN/CRF-receptor system exists in both human and rat adrenals controlling catecholamine secretion and synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194738     DOI: 10.1210/en.2006-0967

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

2.  Evaluation of Serum Urocortin 2 Levels in Patients with Hypertension.

Authors:  Gamze Aslan; Saide Aytekin
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-01-10

3.  Urocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity.

Authors:  Yusu Gu; Kuixing Zhang; Nilima Biswas; Ryan S Friese; Dennis H Lin; Sushil K Mahata; Masahiko Hoshijima; Daniel T O'Connor; Kirk L Peterson; Bhawanjit K Brar
Journal:  Endocrinology       Date:  2010-07-28       Impact factor: 4.736

4.  Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.

Authors:  Ekaterini Chatzaki; Peter A Anton; Mulugeta Million; Maria Lambropoulou; Theodoros Constantinidis; George Kolios; Yvette Taché; Dimitri E Grigoriadis
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

5.  Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors.

Authors:  Eric Gutknecht; Richard L Hauger; Ilse Van der Linden; Georges Vauquelin; Frank M Dautzenberg
Journal:  J Neurochem       Date:  2007-11-01       Impact factor: 5.372

6.  Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular system.

Authors:  Kazuhiro Takahashi
Journal:  Int J Endocrinol       Date:  2012-05-17       Impact factor: 3.257

7.  Maternal exposure to low levels of corticosterone during lactation protects against experimental inflammatory colitis-induced damage in adult rat offspring.

Authors:  Carla Petrella; Chiara Giuli; Simona Agostini; Valérie Bacquie; Manuela Zinni; Vassilia Theodorou; Maria Broccardo; Paola Casolini; Giovanna Improta
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

8.  Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling.

Authors:  Jorge A Rodriguez; Sara Huerta-Yepez; Ivy Ka Man Law; Guillermina J Baay-Guzman; Belen Tirado-Rodriguez; Jill M Hoffman; Dimitrios Iliopoulos; Daniel W Hommes; Hein W Verspaget; Lin Chang; Charalabos Pothoulakis; Stavroula Baritaki
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-11-01

9.  Maternal high-fat diet and obesity impact palatable food intake and dopamine signaling in nonhuman primate offspring.

Authors:  Heidi M Rivera; Paul Kievit; Melissa A Kirigiti; Leigh Ann Bauman; Karalee Baquero; Peter Blundell; Tyler A Dean; Jeanette C Valleau; Diana L Takahashi; Tim Frazee; Luke Douville; Jordan Majer; M Susan Smith; Kevin L Grove; Elinor L Sullivan
Journal:  Obesity (Silver Spring)       Date:  2015-11       Impact factor: 5.002

10.  Early High-Fat Diet Exposure Causes Dysregulation of the Orexin and Dopamine Neuronal Populations in Nonhuman Primates.

Authors:  Cadence True; Anam Arik; Sarah Lindsley; Melissa Kirigiti; Elinor Sullivan; Paul Kievit
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-10       Impact factor: 6.055

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.